EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
Evofem Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01−0.00 (-10.00%)
Close on Oct 19, 2026
- Market cap
- $865.23K
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Evofem Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 9, 2026 | Oct 15, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2026 | Sep 23, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 20, 2026 | Jul 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 8, 2026 | Jul 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 18, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2026 | Apr 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2026 | Mar 11, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 26, 2025 | Nov 26, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 20, 2025 | Oct 20, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2025 | Oct 17, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 22, 2025 | Aug 26, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2025 | Jul 2, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | May 3, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 28, 2025 | Apr 3, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 26, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2024 | Dec 23, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 19, 2024 | Nov 25, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 27, 2024 | Oct 31, 2024 | SEC EDGAR |